Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 1
1968 2
1970 3
1971 4
1972 2
1973 4
1974 3
1975 5
1976 6
1977 5
1978 6
1979 6
1980 8
1981 10
1982 9
1983 14
1984 10
1985 8
1986 14
1987 10
1988 10
1989 7
1990 11
1991 7
1992 7
1993 5
1994 8
1995 6
1996 8
1997 6
1998 12
1999 13
2000 10
2001 9
2002 7
2003 9
2004 9
2005 9
2006 9
2007 9
2008 13
2009 5
2010 8
2011 10
2012 4
2013 2
2014 2
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Follath F, et al. Lancet. 2002 Jul 20;360(9328):196-202. doi: 10.1016/s0140-6736(02)09455-2. Lancet. 2002. PMID: 12133653 Clinical Trial.
[Heart failure].
Follath F, Just H. Follath F, et al. Ther Umsch. 2000 May;57(5):277. doi: 10.1024/0040-5930.57.5.277. Ther Umsch. 2000. PMID: 10905935 German. No abstract available.
Drug-induced pulmonary hypertension?
Follath F, Burkart F, Schweizer W. Follath F, et al. Br Med J. 1971 Jan 30;1(5743):265-6. doi: 10.1136/bmj.1.5743.265. Br Med J. 1971. PMID: 5100497 Free PMC article.
Metabolism of antiarrhythmics.
Ha HR, Follath F. Ha HR, et al. Among authors: follath f. Curr Drug Metab. 2004 Dec;5(6):543-71. doi: 10.2174/1389200043335351. Curr Drug Metab. 2004. PMID: 15578947 Review.
Ethical considerations in cardiovascular prevention.
Follath F. Follath F. Fundam Clin Pharmacol. 2009 Dec;23(6):669-73. doi: 10.1111/j.1472-8206.2009.00695.x. Epub 2009 Jun 4. Fundam Clin Pharmacol. 2009. PMID: 19500153 Review.
The role of β-blockers in the management of hypertension: an Asian perspective.
Tomlinson B, Dalal JJ, Huang J, Low LP, Park CG, Rahman AR, Reyes EB, Soenarta AA, Heagerty A, Follath F. Tomlinson B, et al. Among authors: follath f. Curr Med Res Opin. 2011 May;27(5):1021-33. doi: 10.1185/03007995.2011.562884. Epub 2011 Mar 16. Curr Med Res Opin. 2011. PMID: 21410302 Review.
Can we believe in levosimendan?
Follath F. Follath F. Arq Bras Cardiol. 2008 Mar;90(3):146-7. doi: 10.1590/s0066-782x2008000300001. Arq Bras Cardiol. 2008. PMID: 18392391 Free article. English, Portuguese. No abstract available.
Etiology and response to drug treatment in heart failure.
Follath F, Cleland JG, Klein W, Murphy R. Follath F, et al. J Am Coll Cardiol. 1998 Nov;32(5):1167-72. doi: 10.1016/s0735-1097(98)00400-8. J Am Coll Cardiol. 1998. PMID: 9809921 Free article. Review.
Serum level monitoring of antibacterial drugs. A review.
Wenk M, Vozeh S, Follath F. Wenk M, et al. Among authors: follath f. Clin Pharmacokinet. 1984 Nov-Dec;9(6):475-92. doi: 10.2165/00003088-198409060-00001. Clin Pharmacokinet. 1984. PMID: 6391780 Review.
338 results